Abstract:Gastric cancer (GC) remains a significant public health concern because of its lethality, underscoring the need for deeper insights into its molecular mechanisms. Recent studies have increasingly highlighted the role of epigenetic modifications as critical players in cancer progression. Despite their importance, research specifically addressing epigenetic factors in GC is relatively scarce. This paper seeks to bridge that gap by examining recent literature that elucidates the epigenetic landscape associated with GC. The investigation of long noncoding RNAs (lncRNAs) has revealed their substantial involvement in gene dysregulation and epigenetic alterations within GC tumors. Notably, lncRNAs such as LINC00853 and LINC01266 have been identified as significant contributors to the epigenetic modulation of gene expression. Furthermore, the overexpression of KAT5 and GPX4 has been shown to mitigate the antiproliferative effects resulting from the depletion of circRHOT1, suggesting a complex interplay between these molecules in GC pathophysiology. Another pivotal aspect of epigenetic regulation in GC involves modifications in N6-methyladenosine (m6A), which play crucial roles in mRNA maturation processes such as splicing, export, degradation, and translation. m6A modifications are known for their influence on various cancer-related pathways, thus presenting a potential avenue for targeted interventions. Our findings indicate that the most pronounced instances of epigenetic dysregulation in GC can be traced back to the effects of long lncRNAs and alterations in m6A modification patterns. This underscores the urgent need for comprehensive investigations into these epigenetic factors, as a deeper understanding could lead to enhanced diagnostic markers and innovative therapeutic strategies. The integration of genetic and epigenetic considerations is essential for advancing the field of GC research. This synthesis of recent findings concerning epigenetic regulation offers valuable insights that could inform future studies and therapeutic developments. There is a critical need for ongoing research to elucidate the complexities of epigenetic modifications in GC, ultimately improving patient outcomes through tailored interventions.

Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification

Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.

Epigenetic modifications involving ncRNAs in digestive system cancers: focus on histone modification

Epigenetic Regulation of Long Non-Coding RNAs in Gastric Cancer

Epigenetic Biomarkers: Potential Applications in Gastrointestinal Cancers.

Gastric Cancer: an Epigenetic View

Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis

Epigenetic Regulation of DNA Methylation and RNA Interference in Gastric Cancer: A 2024 Update

Non-coding RNA Methylation Modifications in Hepatocellular Carcinoma: Interactions and Potential Implications

Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications

The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer

Epigenetic Regulation of Micrornas in Gastric Cancer

Methylation Modification In Gastric Cancer And Approaches To Targeted Epigenetic Therapy

Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology

Advances in Study on Histone Modification in Gastric Cancer

Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers

Epigenetic roles in the malignant transformation of gastric mucosal cells

Epigenetics on Gastric Cancer Research

Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer

Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives

Progress and application of epitranscriptomic m6A modification in gastric cancer